- Home
- GOSS vs ITRG Comparison
GOSS vs ITRG Comparison
Compare GOSS & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- ITRG
- Stock Information
- Founded
- GOSS 2015
- ITRG 1997
- Country
- GOSS United States
- ITRG Canada
- Employees
- GOSS N/A
- ITRG N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- GOSS Health Care
- ITRG Basic Materials
- Exchange
- GOSS Nasdaq
- ITRG Nasdaq
- Market Cap
- GOSS 262.5M
- ITRG 277.2M
- IPO Year
- GOSS 2019
- ITRG N/A
- Fundamental
- Price
- GOSS $1.23
- ITRG $1.50
- Analyst Decision
- GOSS Strong Buy
- ITRG Strong Buy
- Analyst Count
- GOSS 4
- ITRG 1
- Target Price
- GOSS $7.75
- ITRG $2.75
- AVG Volume (30 Days)
- GOSS 2.6M
- ITRG 1.3M
- Earning Date
- GOSS 08-11-2025
- ITRG 08-13-2025
- Dividend Yield
- GOSS N/A
- ITRG N/A
- EPS Growth
- GOSS N/A
- ITRG N/A
- EPS
- GOSS N/A
- ITRG N/A
- Revenue
- GOSS $124,590,000.00
- ITRG $87,375,000.00
- Revenue This Year
- GOSS N/A
- ITRG $746.16
- Revenue Next Year
- GOSS $91.14
- ITRG N/A
- P/E Ratio
- GOSS N/A
- ITRG N/A
- Revenue Growth
- GOSS N/A
- ITRG N/A
- 52 Week Low
- GOSS $0.66
- ITRG $0.79
- 52 Week High
- GOSS $1.55
- ITRG $1.95
- Technical
- Relative Strength Index (RSI)
- GOSS 54.09
- ITRG 42.30
- Support Level
- GOSS $1.25
- ITRG $1.41
- Resistance Level
- GOSS $1.44
- ITRG $1.74
- Average True Range (ATR)
- GOSS 0.10
- ITRG 0.09
- MACD
- GOSS -0.00
- ITRG -0.02
- Stochastic Oscillator
- GOSS 41.67
- ITRG 27.27
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.